GABAergic synaptic transmission : molecular, pharmacological, and clinical aspects /
Corporate Author: | |
---|---|
Other Authors: | , , |
Format: | Conference Proceeding Book |
Language: | English |
Published: |
New York :
Raven Press,
[1992], ©1992
New York : ©1992 New York: c1992 New York : [1992] |
Series: | Advances in biochemical psychopharmacology ;
v. 47 Advances in biochemical psychopharmacology ; v. 47 Advances in biochemical psychopharmacology v. 47 |
Subjects: |
LEADER | 08499nam a2201705 a 4500 | ||
---|---|---|---|
001 | f834e933-e41f-47b7-942f-aff35cda6e75 | ||
005 | 20240904000000.0 | ||
008 | 920313s1992 nyua b 001 0 eng | ||
010 | |a 92011898 | ||
010 | |a 92011898 | ||
010 | |a 92011898 | ||
010 | |a ^^^92011898^ | ||
016 | 7 | |a 9203817 |2 DNLM | |
019 | |a 25508637 |a 26505630 |a 1167001997 | ||
019 | |a 25508637 |a 26505630 | ||
020 | |a 0881679232 | ||
020 | |a 9780881679236 | ||
035 | |9 ADG6879TS | ||
035 | |9 AGC9712HS | ||
035 | |9 FGY5752YL | ||
035 | |a (CStRLIN)NJPG92-B36291 | ||
035 | |a (CStRLIN)NYCM92-B3601 | ||
035 | |a (NNC)3966225 | ||
035 | |a (NcD)001051355DUK01 | ||
035 | |a (NjP)730297-princetondb | ||
035 | |a (OCoLC)25547692 |z (OCoLC)25508637 |z (OCoLC)26505630 |z (OCoLC)1167001997 |z (OCoLC)1421248408 | ||
035 | |a (OCoLC)25547692 |z (OCoLC)25508637 |z (OCoLC)26505630 | ||
035 | |a (OCoLC)25547692 | ||
035 | |a (OCoLC)ocm25547692 | ||
035 | |a (OCoLC)ocm25547692 | ||
035 | |a (OCoLC)ocn689754138 | ||
035 | |a (PU)1707442-penndb-Voyager | ||
035 | |a 25547692 | ||
035 | |a 3367857 | ||
035 | |a 3966225 | ||
035 | |z (NjP)Voyager730297 | ||
040 | |a DNLM/DLC |b eng |c DLC |d NDK | ||
040 | |a DNLM/DLC |b eng |c DLC |d NLM |d TMV |d MUQ |d NLGGC |d BTCTA |d YDXCP |d BAKER |d OCLCQ |d ZWZ |d BDX |d GBVCP |d OCLCO |d OCLCQ |d EUW |d OCLCQ |d OCLCF |d OCLCO | ||
040 | |a DNLM/DLC |c DLC |d DLC |d CtY | ||
040 | |a DNLM/DLC |c DLC |d DLC |d NNC-M | ||
040 | |a DNLM/DLC |c DLC |d NLM |d HMS | ||
050 | 0 | 0 | |a RM315 |b .A4 vol. 47 |a QP563.G32 |
060 | |a W1 AD437 v.47 | ||
060 | |a WL 102.8 G112 | ||
060 | 0 | |a W1 AD437 v.47 |a WL 102.8 G112 | |
060 | 0 | |a W1 |b AD437 v.47 (P) |a [WL 102.8 G112] | |
060 | 0 | 0 | |a W1 |b AD437 v.47 1992 |
060 | 1 | 0 | |a WL 102.8 |b G112 1992 |
079 | |a 25547692 | ||
082 | 0 | 0 | |a 615/.78 s |a 615/.78 |2 20 |
084 | |a 44.38 |2 bcl | ||
084 | |a 44.90 |2 bcl | ||
245 | 0 | 0 | |a GABAergic synaptic transmission : |b molecular, pharmacological, and clinical aspects / |c volume editors, Giovanni Biggio, Alessandra Concas, Erminio Costa |
260 | |a New York : |b Raven Press, |c [1992], ©1992 | ||
260 | |a New York : |b Raven Press, |c ©1992 | ||
260 | |a New York: |b Raven Press, |c c1992 | ||
264 | 1 | |a New York : |b Raven Press, |c [1992] | |
264 | 4 | |c ©1992 | |
300 | |a xxiii, 469 pages : |b illustrations ; |c 24 cm | ||
300 | |a xxiv, 469 p. : |b ill | ||
300 | |a xxiv, 469 p. : |b ill. ; |c 24 cm | ||
300 | |a xxiv, 469 p. : |b ill. ; |c 25 cm | ||
300 | |a xxiv, 469 pages : |b illustrations ; |c 25 cm | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a unmediated |b n |2 rdamedia | ||
337 | |a unspecified |b z |2 rdamedia | ||
338 | |a unspecified |b zu |2 rdacarrier | ||
338 | |a volume |b nc |2 rdacarrier | ||
440 | 0 | |a Advances in biochemical psychopharmacology ; |v v. 47 | |
490 | 1 | |a Advances in biochemical psychopharmacology ; |v v. 47 | |
500 | |a This WorldCat-derived record is shareable under Open Data Commons ODC-BY, with attribution to OCLC |5 CTY | ||
500 | |a "Proceedings of the 7th Sardinian Conference on Neuroscience held at Domus de Maria (Cagliari), Italy, in June 1991."--Acknowledgments | ||
504 | |a Includes bibliographical references and index | ||
505 | 0 | |a Molecular biology and molecular pharmacology -- Allosteric modulators: the neurosteroids -- GABA(A)/Benzodiazepine receptor subclasses -- Ethanol and general -- Benzodiazepines vs. non-benzodiazepine GABAergic drugs | |
650 | 0 | |a Alcohol |x Physiological effect | |
650 | 0 | |a Anesthetics |x Physiological effect | |
650 | 0 | |a Benzodiazepines |x Receptors | |
650 | 0 | |a GABA |x Receptors | |
650 | 0 | |a Molecular pharmacology | |
650 | 0 | |a Neural receptors |x Physiology |v Congresses | |
650 | 0 | |a Neural transmission | |
650 | 0 | |a Receptors, Synaptic |x Physiology |v Congresses | |
650 | 0 | |a Receptors, Synaptic |x physiology |v Congresses | |
650 | 0 | |a Steroids |x Physiological effect | |
650 | 2 | |a Receptors, GABA | |
650 | 2 | |a Receptors, GABA-A |x genetics |v Congresses | |
650 | 2 | |a Receptors, GABA-A |x genetics | |
650 | 2 | |a Receptors, GABA-A |x physiology |v Congresses | |
650 | 2 | |a Receptors, GABA-A |x physiology | |
650 | 2 | |a Receptors, Neurotransmitter |x physiology | |
650 | 2 | |a Synaptic Transmission |v Congresses | |
650 | 2 | |a Synaptic Transmission | |
650 | 6 | |a Alcool |x Effets physiologiques | |
650 | 6 | |a Anesthésiques |x Effets physiologiques | |
650 | 6 | |a Benzodiazépines |x Récepteurs | |
650 | 6 | |a GABA |x Récepteurs | |
650 | 6 | |a Pharmacologie moléculaire | |
650 | 6 | |a Stéroïdes |x Effets physiologiques | |
650 | 6 | |a Transmission nerveuse | |
650 | 7 | |a Alcohol |x Physiological effect |2 fast | |
650 | 7 | |a Anesthetics |x Physiological effect |2 fast | |
650 | 7 | |a Benzodiazepines |x Receptors |2 fast | |
650 | 7 | |a Benzodiazépines |x Récepteurs |x Congrès |2 ram | |
650 | 7 | |a GABA |x Receptors |2 fast | |
650 | 7 | |a GABA |x Récepteurs |x Congrès |2 ram | |
650 | 7 | |a Molecular pharmacology |2 fast | |
650 | 7 | |a Neural transmission |2 fast | |
650 | 7 | |a Récepteur GABA-benzodiazépine |x Génétique |x Actes de congrès |2 fmesh | |
650 | 7 | |a Récepteur GABA-benzodiazépine |x Physiologie |x Actes de congrès |2 fmesh | |
650 | 7 | |a Steroids |2 fast | |
650 | 7 | |a Steroids |x Physiological effect |2 fast | |
650 | 7 | |a Transmission synaptique |x Actes de congrès |2 fmesh | |
653 | 0 | |a Alcohol |a Physiological effect | |
653 | 0 | |a Anesthetics |a Physiological effect | |
653 | 0 | |a Benzodiazepines |a Receptors | |
653 | 0 | |a GABA |a Receptors | |
653 | 0 | |a Molecular pharmacology | |
653 | 0 | |a Neural transmission | |
653 | 0 | |a Receptors, Synaptic |a physiology |a congresses | |
653 | 0 | |a Steroids |a Physiological effect | |
655 | 2 | |a Congress | |
655 | 4 | |a Conference proceedings | |
655 | 7 | |a Actes de congrès |2 rvmgf | |
655 | 7 | |a Conference papers and proceedings |2 fast | |
655 | 7 | |a Conference papers and proceedings |2 lcgft | |
700 | 1 | |a Biggio, Giovanni |0 http://viaf.org/viaf/62138025 | |
700 | 1 | |a Biggio, Giovanni | |
700 | 1 | |a Concas, Alessandra |0 http://viaf.org/viaf/43505353 | |
700 | 1 | |a Concas, Alessandra | |
700 | 1 | |a Costa, Erminio |0 http://viaf.org/viaf/15427193 | |
700 | 1 | |a Costa, Erminio | |
711 | 2 | |a Sardinian Conference on Neuroscience |n (7th : |d 1991 : |c Domus de Maria (Cagliari), Italy) | |
776 | 0 | 8 | |i Online version: |t GABAergic synaptic transmission |d New York : Raven Press, ©1992 |w (OCoLC)1019679286 |
830 | 0 | |a Advances in biochemical psychopharmacology ; |v v. 47 | |
830 | 0 | |a Advances in biochemical psychopharmacology |v v. 47 | |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 3367857 |s US-CTY |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 990014890670203941 |s US-MH |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 990010513550108501 |s US-NCD |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 997302973506421 |s US-NJP |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 3966225 |s US-NNC |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 0 | |i f834e933-e41f-47b7-942f-aff35cda6e75 |l 9917074423503681 |s US-PU |m gabaergic_synaptic_transmissionmolecular_pharmacological_and_clinical______1992_______ravena___________________________________________________________________________p |
999 | 1 | 1 | |l 990014890670203941 |s ISIL:US-MH |t BKS |a MED GEN |b 32044015340169 |c QV 77 A245 v.47 1992 |d 2 |x 01 BOOK |y 231793266580003941 |p LOANABLE |
999 | 1 | 1 | |l 990010513550108501 |s ISIL:US-NCD |t BKS |a MCL MSTKS |b M00002260A |c QV77 Ad95 v.47 1992 |d 2 |x BOOK |y 23709260860008501 |p UNLOANABLE |
999 | 1 | 1 | |l 997302973506421 |s ISIL:US-NJP |t BKS |a recap pa |b 32101055932147 |c 8929.112 vol.47 |d 8 |x Gen |y 23530548800006421 |p LOANABLE |
999 | 1 | 1 | |l 3966225 |s ISIL:US-NNC |t BKS |a off,hsl |b HS64748642 |c QP563.G32 G332 1992 |y 4060049 |p LOANABLE |